Financhill
Back

KalVista Pharmaceuticals Quote, Financials, Valuation and Earnings

KalVista Pharmaceuticals Price Quote

$9.11
-0.33 (-3.5%)
(Updated: December 11, 2024 at 5:55 PM ET)

KalVista Pharmaceuticals Key Stats

Buy
51
KalVista Pharmaceuticals (KALV) is a Buy

Day range:
$9.13 - $9.59
52-week range:
$8.19 - $16.88
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
31.82
P/B ratio:
3.48%

Volume:
247.6K
Avg. volume:
411.4K
1-year change:
15.69%
Market cap:
$466.5M
Revenue:
$0
EPS:
$-3.69

How Much Does KalVista Pharmaceuticals Make?

Data Unavailable

Is KalVista Pharmaceuticals Growing As A Company?

Data Unavailable

KalVista Pharmaceuticals Stock Price Performance

What Is KalVista Pharmaceuticals 52-Week High & Low?

KalVista Pharmaceuticals Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy KalVista Pharmaceuticals?

Is KalVista Pharmaceuticals Cash Flow Positive?

  • What Is KALV Cash Flow From Operations?
    Cash flow from operations (TTM) is -$122.5M
  • What Is KalVista Pharmaceuticals’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $153.7M
  • What Is KalVista Pharmaceuticals’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$47.1M

KalVista Pharmaceuticals Return On Invested Capital

Data Unavailable

KalVista Pharmaceuticals Earnings Date & Stock Price

KalVista Pharmaceuticals Competitors

KalVista Pharmaceuticals Dividend Yield

KalVista Pharmaceuticals Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -0.22%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 5
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 28.50
Upside from Last Price: 201.91%

Major Shareholders

  • How many KALV shares are owned by institutional investors?
    67.4M KALV shares are owned by institutional investors
  • How many KALV shares are owned by insiders?
    748.8K KALV shares are owned by insiders